$AVD
AMERICAN VANGUARD CORP

2015 Q4 Form 10-Q Financial Statement

#000119312515363501 Filed on November 03, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2015 Q1
Revenue $83.81M $72.49M $66.57M
YoY Change 8.01% 1.19% -17.92%
Cost Of Revenue $53.10M $41.05M $41.92M
YoY Change 14.44% -5.28% -19.69%
Gross Profit $30.70M $31.43M $24.65M
YoY Change -1.73% 11.1% -14.72%
Gross Profit Margin 36.63% 43.36% 37.03%
Selling, General & Admin $21.90M $21.60M $19.50M
YoY Change -10.98% 0.47% -3.47%
% of Gross Profit 71.34% 68.72% 79.11%
Research & Development $4.200M $4.500M $4.800M
YoY Change -32.26% -13.46% 2.13%
% of Gross Profit 13.68% 14.32% 19.47%
Depreciation & Amortization $4.280M $2.231M $3.954M
YoY Change -1.15% -44.23% 5.92%
% of Gross Profit 13.94% 7.1% 16.04%
Operating Expenses $26.10M $26.06M $24.34M
YoY Change -15.26% -4.78% -3.39%
Operating Profit $4.598M $5.374M $306.0K
YoY Change 949.77% 480.35% -91.74%
Interest Expense -$600.0K $700.0K $641.0K
YoY Change -25.0% -12.94% 1.58%
% of Operating Profit -13.05% 13.03% 209.48%
Other Income/Expense, Net
YoY Change
Pretax Income $4.000M $4.736M -$335.0K
YoY Change -1100.0% 3121.77% -110.83%
Income Tax $1.100M $1.643M -$292.0K
% Of Pretax Income 27.5% 34.69%
Net Earnings $2.987M $2.772M $51.00K
YoY Change 65.48% 278.69% -97.64%
Net Earnings / Revenue 3.56% 3.82% 0.08%
Basic Earnings Per Share $0.10 $0.10 $0.00
Diluted Earnings Per Share $0.10 $0.09 $0.00
COMMON SHARES
Basic Shares Outstanding 29.16M shares 28.75M shares 28.53M shares
Diluted Shares Outstanding 29.29M shares 28.84M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.500M $5.400M $6.900M
YoY Change 12.24% 8.0% -17.86%
Cash & Equivalents $5.524M $5.429M $6.870M
Short-Term Investments
Other Short-Term Assets $11.20M $20.80M $23.30M
YoY Change -49.32% 0.97% 22.63%
Inventory $136.5M $161.5M $167.0M
Prepaid Expenses $11.17M
Receivables $72.84M $89.72M $82.03M
Other Receivables $2.554M $4.872M $2.784M
Total Short-Term Assets $228.6M $283.6M $288.3M
YoY Change -20.38% -2.71% -4.36%
LONG-TERM ASSETS
Property, Plant & Equipment $47.97M $48.46M $49.19M
YoY Change -4.11% -5.38% -5.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.536M $2.592M $3.172M
YoY Change -20.05% -14.23% 20.65%
Other Assets $29.58M $30.83M $34.61M
YoY Change -15.58% -16.76% -11.43%
Total Long-Term Assets $206.7M $210.3M $182.4M
YoY Change 11.57% 10.42% -7.24%
TOTAL ASSETS
Total Short-Term Assets $228.6M $283.6M $288.3M
Total Long-Term Assets $206.7M $210.3M $182.4M
Total Assets $435.3M $493.9M $470.7M
YoY Change -7.84% 2.48% -5.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.34M $23.42M $23.98M
YoY Change -24.83% 30.59% -40.32%
Accrued Expenses $44.37M $73.53M $58.00M
YoY Change -15.56% 1.01% -6.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $55.00K $10.07M $272.0K
YoY Change -22.54% 14087.32% 288.57%
Total Short-Term Liabilities $88.71M $114.7M $93.90M
YoY Change 9.19% 13.94% -16.25%
LONG-TERM LIABILITIES
Long-Term Debt $68.32M $82.66M $85.04M
YoY Change -30.71% -13.06% -14.2%
Other Long-Term Liabilities $3.054M $3.003M $3.022M
YoY Change -7.71% -11.15% -32.84%
Total Long-Term Liabilities $71.38M $85.66M $88.06M
YoY Change -29.97% -12.99% -11.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $88.71M $114.7M $93.90M
Total Long-Term Liabilities $71.38M $85.66M $88.06M
Total Liabilities $166.9M $228.5M $210.1M
YoY Change -21.0% 2.88% -12.1%
SHAREHOLDERS EQUITY
Retained Earnings $208.5M $205.5M $202.0M
YoY Change 2.97% 2.12% -0.61%
Common Stock $71.70M $71.63M $3.157M
YoY Change 3.33% 2169.61% 1.22%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.269M $8.269M $8.269M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares $2.451M 2.451M shares 2.451M shares
Shareholders Equity $268.4M $265.4M $261.3M
YoY Change
Total Liabilities & Shareholders Equity $435.3M $493.9M $470.7M
YoY Change -7.84% 2.48% -5.5%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2015 Q1
OPERATING ACTIVITIES
Net Income $2.987M $2.772M $51.00K
YoY Change 65.48% 278.69% -97.64%
Depreciation, Depletion And Amortization $4.280M $2.231M $3.954M
YoY Change -1.15% -44.23% 5.92%
Cash From Operating Activities $26.76M $7.990M $19.84M
YoY Change -10392.31% -266.46% -147.36%
INVESTING ACTIVITIES
Capital Expenditures -$1.700M -$1.720M -$1.520M
YoY Change 38.21% -14.0% -16.48%
Acquisitions
YoY Change
Other Investing Activities -$230.0K $0.00
YoY Change -54.0%
Cash From Investing Activities -$1.930M -$1.720M -$1.520M
YoY Change 11.56% -14.0% -16.3%
FINANCING ACTIVITIES
Cash Dividend Paid $569.0K
YoY Change -59.87%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -24.61M -5.060M -16.08M
YoY Change -1018.28% -162.7% -135.42%
NET CHANGE
Cash From Operating Activities 26.76M 7.990M 19.84M
Cash From Investing Activities -1.930M -1.720M -1.520M
Cash From Financing Activities -24.61M -5.060M -16.08M
Net Change In Cash 220.0K 1.210M 2.240M
YoY Change -68.12% -4.72% 32.39%
FREE CASH FLOW
Cash From Operating Activities $26.76M $7.990M $19.84M
Capital Expenditures -$1.700M -$1.720M -$1.520M
Free Cash Flow $28.46M $9.710M $21.36M
YoY Change 2834.02% -446.79% -153.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.2927 pure
CY2014Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
51156000
CY2014Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7473000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5045000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
697854 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.71
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.21
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2218000
CY2015Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
260603000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660573 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.72
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.29
CY2015Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2541000
CY2015Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
262883000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
633991 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.73
CY2015Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.2118 pure
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2015Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.02
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.25
CY2015Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2450634 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31623810 shares
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2015Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
273711000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
114650000
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
89639000
CY2015Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
82658000
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
28159000
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
73528000
CY2015Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
10073000
CY2015Q3 us-gaap Liabilities
Liabilities
228470000
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
3163000
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
68466000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
287000
CY2015Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
6540000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3003000
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
38000
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3438000
CY2015Q3 us-gaap Minority Interest
MinorityInterest
1000
CY2015Q3 us-gaap Long Term Debt
LongTermDebt
92731000
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
205520000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
265442000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
493913000
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
265443000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
23421000
CY2015Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1050000
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
128788000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48460000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
283619000
CY2015Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
32708000
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8731000
CY2015Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4872000
CY2015Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4819000
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
131006000
CY2015Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1233000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5429000
CY2015Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
94595000
CY2015Q3 us-gaap Treasury Stock Value
TreasuryStockValue
8269000
CY2015Q3 us-gaap Assets
Assets
493913000
CY2015Q3 us-gaap Equity Method Investments
EquityMethodInvestments
2592000
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12135000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89723000
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
138099000
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30828000
CY2015Q3 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
3999000
CY2015Q3 us-gaap Inventory Net
InventoryNet
161496000
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29160234 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6680000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
724904 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.82
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.22
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2450634 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31550477 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2014Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
269906000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
81245000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
83215000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
98605000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
28159000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52546000
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
71000
CY2014Q4 us-gaap Liabilities
Liabilities
211318000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
3156000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
66232000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
166000
CY2014Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
5962000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3309000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
898000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1970000
CY2014Q4 us-gaap Minority Interest
MinorityInterest
-634000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
98676000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
202488000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
261637000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
472321000
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
261003000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
20411000
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1357000
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
142853000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50026000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
287049000
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22778000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
8731000
CY2014Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2396000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
100211000
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
5964000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4885000
CY2014Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
88423000
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
8269000
CY2014Q4 us-gaap Assets
Assets
472321000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13415000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
86027000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
133241000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35035000
CY2014Q4 us-gaap Inventory Net
InventoryNet
165631000
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3687000
CY2015Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
569000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6183 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28422000 shares
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-33836000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28888000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
466000 shares
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
263000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3114000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1371000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3119000
us-gaap Operating Income Loss
OperatingIncomeLoss
5355000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
16995000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31690000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
56000
us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
426000
us-gaap Sales Revenue Net
SalesRevenueNet
221043000
us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
954000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-459000
us-gaap Payments Of Dividends
PaymentsOfDividends
4251000
us-gaap Profit Loss
ProfitLoss
2584000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
195254000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-633000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
328000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
5947000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5237000
us-gaap Net Income Loss
NetIncomeLoss
3036000
us-gaap Gross Profit
GrossProfit
83258000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-32000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-348000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1531000
us-gaap Interest Expense
InterestExpense
2292000
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
300000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-328000
us-gaap Operating Expenses
OperatingExpenses
77903000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
249000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
38476000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
7937000
us-gaap Cost Of Revenue
CostOfRevenue
137785000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11996000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
856000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3046000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-452000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
4332000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2769000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1307000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3046000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
15964000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
43450000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-22341000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
263000
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
1616000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5947000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
25789000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
2263000
avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
321000
us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
dei Document Type
DocumentType
10-Q
dei Trading Symbol
TradingSymbol
AVD
dei Entity Central Index Key
EntityCentralIndexKey
0000005981
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2015-04-03
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28653000 shares
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2015-04-17
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.19 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
51807000
dei Amendment Flag
AmendmentFlag
false
us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2015-03-16
dei Entity Registrant Name
EntityRegistrantName
AMERICAN VANGUARD CORP
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29208000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
555000 shares
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
8000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2136000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1252000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4938000
us-gaap Payments To Acquire Additional Interest In Subsidiaries
PaymentsToAcquireAdditionalInterestInSubsidiaries
125000
us-gaap Operating Income Loss
OperatingIncomeLoss
6879000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
4739000
us-gaap Cost Of Revenue
CostOfRevenue
124370000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12190000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
958000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2943000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-204000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
3992000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
10000000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-860000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
6172000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4135000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
149000
us-gaap Sales Revenue Net
SalesRevenueNet
205574000
us-gaap Payments Of Dividends
PaymentsOfDividends
1141000
us-gaap Profit Loss
ProfitLoss
3400000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
180954000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-580000
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
36435000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
5196000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1143000
us-gaap Net Income Loss
NetIncomeLoss
3604000
us-gaap Gross Profit
GrossProfit
81204000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1468000
us-gaap Interest Expense
InterestExpense
2090000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1256000
us-gaap Operating Expenses
OperatingExpenses
74325000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
118000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-8251000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1800000
us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
338000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2943000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
22597000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-16120000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3010000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
8000
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
254000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-41756000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
24620000
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.49
CY2015Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2015Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
34800 shares
CY2015Q2 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
12000
CY2015Q2 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
6000
avd Cash Dividend Paid
CashDividendPaid
572000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
3980000
avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-580000
CY2014Q4 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
500000
CY2014Q4 avd Stock And Warrants Issued During Period Shares Preferred Stocks And Warrants
StockAndWarrantsIssuedDuringPeriodSharesPreferredStocksAndWarrants
6155000 shares
CY2015Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10400 shares
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.49
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
16650 shares
CY2015Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
280000
CY2015Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1000
CY2015Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1245000
CY2015Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1427000
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-43000
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-248000
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-248000
CY2015Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
572000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2481 shares
CY2015Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
937000
CY2015Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1058000
CY2015Q2 us-gaap Profit Loss
ProfitLoss
739000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-323000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-323000
CY2015Q2 avd Adjustment And Purchase Of Noncontrolling Interest
AdjustmentAndPurchaseOfNoncontrollingInterest
-125000
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1207 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28466000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28797000 shares
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
331000 shares
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
386000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
147000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
926000
CY2014Q3 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
25000
CY2014Q3 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
145000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
71635000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-146000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
608000
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
64700000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
732000
CY2014Q3 us-gaap Gross Profit
GrossProfit
28293000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-1000
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-491000
CY2014Q3 us-gaap Interest Expense
InterestExpense
804000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
27367000
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
43342000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-124000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1240000
CY2014Q3 avd Sales Of Non Crop Products
SalesOfNonCropProducts
6935000
CY2014Q3 avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
147000
CY2014Q3 avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
461000
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
22582 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28753000 shares
CY2015Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.49
CY2015Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2015Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4000 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29289000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
536000 shares
CY2015Q3 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
305000
CY2015Q3 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1875000
CY2015Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-11000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4736000
CY2015Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
458000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5374000
CY2015Q3 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
62000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
72486000
CY2015Q3 us-gaap Profit Loss
ProfitLoss
2704000
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
63641000
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-389000
CY2015Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
2772000
CY2015Q3 us-gaap Gross Profit
GrossProfit
31433000
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-897000
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-897000
CY2015Q3 us-gaap Interest Expense
InterestExpense
700000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
26059000
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
41053000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1643000
CY2015Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-68000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
458000
CY2015Q3 avd Sales Of Non Crop Products
SalesOfNonCropProducts
8845000
CY2015Q3 avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
3093000
CY2015Q3 avd Income Loss From Equity Method Investments Net Of Gain Loss On Dilution
IncomeLossFromEquityMethodInvestmentsNetOfGainLossOnDilution
-389000

Files In Submission

Name View Source Status
0001193125-15-363501-index-headers.html Edgar Link pending
0001193125-15-363501-index.html Edgar Link pending
0001193125-15-363501.txt Edgar Link pending
0001193125-15-363501-xbrl.zip Edgar Link pending
avd-20150930.xml Edgar Link completed
avd-20150930.xsd Edgar Link pending
avd-20150930_cal.xml Edgar Link unprocessable
avd-20150930_def.xml Edgar Link unprocessable
avd-20150930_lab.xml Edgar Link unprocessable
avd-20150930_pre.xml Edgar Link unprocessable
d192076d10q.htm Edgar Link pending
d192076dex311.htm Edgar Link pending
d192076dex312.htm Edgar Link pending
d192076dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending